Sanara Medtech Stock Investor Sentiment

SMTI Stock  USD 35.91  0.71  1.94%   
Under 68% of Sanara Medtech's investor base is looking to short. The analysis of overall sentiment of trading Sanara Medtech stock suggests that many investors are alarmed at this time. Sanara Medtech's investing sentiment shows overall attitude of investors towards Sanara Medtech.
  

Sanara Medtech Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Sanara Medtech can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
few days ago at thelincolnianonline.com         
Sanara MedTech Furnishes Investor Presentation for Piper Sandler 36th Annual Healthcare Conference
news
few days ago at www.macroaxis.com         
Acquisition by Ortwein Sara N of 4799 shares of Sanara Medtech subject to Rule 16b-3
Macroaxis News
over a week ago at news.google.com         
Sanara MedTech to Present at Healthcare Conference - TipRanks
Google News at Macroaxis
over two weeks ago at gurufocus.com         
Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th
Gurufocus Stories at Macroaxis
over three weeks ago at zacks.com         
All You Need to Know About Sanara MedTech Rating Upgrade to Buy
zacks News
over three weeks ago at news.google.com         
Sanara MedTech Inc. Shares Sold by Janney Montgomery Scott LLC - MarketBeat
Google News at Macroaxis
over three weeks ago at finance.yahoo.com         
Sanara MedTech Inc. Just Reported Earnings, And Analysts Cut Their Target Price
Yahoo News
over three weeks ago at simplywall.st         
US44.00 Thats What Analysts Think Sanara MedTech Inc. Is Worth After Its Latest Results
Simply Wall St News at Macroaxis
over three weeks ago at gurufocus.com         
Sanara MedTech Inc Q3 2024 Earnings Call Highlights Record Revenue Growth and Strategic ...
Gurufocus Stories at Macroaxis
over three weeks ago at insidermonkey.com         
Sanara MedTech Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
over three weeks ago at news.google.com         
Sanara MedTech Reports Strong Revenue Growth Amid Challenges - TipRanks
Google News at Macroaxis
over three weeks ago at gurufocus.com         
Sanara MedTech Inc Q3 2024 Earnings Revenue Surpasses Estimates at 21. ...
Gurufocus Stories at Macroaxis
over a month ago at gurufocus.com         
Sanara MedTech Inc Q3 2024 Everything You Need To Know Ahead Of Earnings
Gurufocus Stories at Macroaxis
over a month ago at gurufocus.com         
Acquisition by Myers Keith G of 1975 shares of Sanara Medtech subject to Rule 16b-3
Gurufocus Stories at Macroaxis
over a month ago at www.macroaxis.com         
Acquisition by Morrison Christopher A. of 7135 shares of Sanara Medtech subject to Rule 16b-3
Macroaxis News
Far too much social signal, news, headlines, and media speculation about Sanara Medtech that are available to investors today. That information is available publicly through Sanara media outlets and privately through word of mouth or via Sanara internal channels. However, regardless of the origin, that massive amount of Sanara data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Sanara Medtech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Sanara Medtech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Sanara Medtech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Sanara Medtech alpha.

Sanara Medtech Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Sanara MedTechs investors will be pleased with their solid 259 percent return over the last five years
09/24/2024
2
Acquisition by Ortwein Sara N of 3440 shares of Sanara Medtech subject to Rule 16b-3
10/03/2024
3
Insider Trading
10/04/2024
4
Sanara MedTech Inc. Announces Changes to Its Board of Directors
10/07/2024
5
Sanara MedTech Inc Stock Price Up 4.87 percent on Oct 18
10/18/2024
6
Sanara MedTech Inc. insiders have significant skin in the game with 30 percent ownership
11/04/2024
7
Acquisition by Morrison Christopher A. of 7135 shares of Sanara Medtech subject to Rule 16b-3
11/07/2024
8
Sanara MedTech Inc Q3 2024 Everything You Need To Know Ahead Of Earnings
11/11/2024
9
Sanara MedTech Inc. Q3 2024 Earnings Call Transcript
11/14/2024
10
US44.00 Thats What Analysts Think Sanara MedTech Inc. Is Worth After Its Latest Results
11/15/2024
11
Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th
11/25/2024
12
Acquisition by Ortwein Sara N of 4799 shares of Sanara Medtech subject to Rule 16b-3
12/06/2024

Complementary Tools for Sanara Stock analysis

When running Sanara Medtech's price analysis, check to measure Sanara Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sanara Medtech is operating at the current time. Most of Sanara Medtech's value examination focuses on studying past and present price action to predict the probability of Sanara Medtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sanara Medtech's price. Additionally, you may evaluate how the addition of Sanara Medtech to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Global Correlations
Find global opportunities by holding instruments from different markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios